Physician profile
Devang Patel
NPI 1629005707
$1,857.22
in general payments reported to CMS, 2019-2025
7 companies · $189 in 2025
The $189 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $261 · 2021: $270 · 2022: $107 · 2023: $559 · 2024: $209 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $453.53 | 2019-2024 | On-Q* Pump and Accessories |
| Edwards Lifesciences Corporation | $440.66 | 2019-2024 | Hemosphere |
| Acacia Pharma INC | $302.20 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $288.77 | 2019-2025 | Exparel, Iovera |
| Merck Sharp & Dohme LLC | $235.92 | 2019-2025 | Bridion |
| Heron Therapeutics, INC. | $113.09 | 2023 | Zynrelef |
| Madrigal Pharmaceuticals | $23.05 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devang Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.